Ambulatory Diagnosis and Treatment of Nonmalignant Pain in the United States, 2000–2010

Abstract

Background Escalating rates of prescription opioid use and abuse have occurred in the context of efforts to improve the treatment of non-malignant pain. Objectives To characterize the diagnosis and management of non-malignant pain in ambulatory, office-based settings in the United States between 2000 and 2010. Design, setting, and participants Serial cross-sectional and multivariate regression analyses of the National Ambulatory Medical Care Survey (NAMCS), a nationally representative audit of office-based physician visits. Measures (1) Annual visits volume among adults with primary pain symptom or diagnosis; (2) receipt of any pain treatment; and (3) receipt of prescription opioid or non-opioid pharmacologic therapy in visits for new musculoskeletal pain. Results Primary symptoms or diagnoses of pain consistently represented one-fifth of visits, varying little from 2000 through 2010. Among all pain visits, opioid prescribing nearly doubled from 11.3% to 19.6%, whereas non-opioid analgesic prescribing remained unchanged (26%–29% of visits). One-half of new musculoskeletal pain visits resulted in pharmacologic treatment, though the prescribing of non-opioid pharmacotherapies decreased from 38% of visits (2000) to 29% of visits (2010). After adjusting for potentially confounding covariates, few patient, physician or practice characteristics were associated with a prescription opioid rather than a non-opioid analgesic for new musculoskeletal pain, and increases in opioid prescribing generally occurred non-selectively over time. Conclusions Increased opioid prescribing has not been accompanied by similar increases in non-opioid analgesics or the proportion of ambulatory pain patients receiving pharmacologic treatment. Clinical alternatives to prescription opioids may be underutilized as a means of treating ambulatory non-malignant pain.

Trends in Prevalent and Incident Opioid Receipt: an Observational Study in Veterans Health Administration 2004–2012

“…[1][2][3][4][5][6] Increased use is variously quantified as number of opioid prescriptions, 7 percentage of primary care visits resulting in opioid prescription, [8][9][10] opioid sales in milligrams per 10,000 capita, 11 and average dose of medication per health plan participant. 12 However, these data can be difficult to interpret.…”

Prescription Opioid Exposures Among Children and Adolescents in the United States: 2000–2015

“…1,2 Eighty percent of opioid prescriptions worldwide are distributed in the United States. 3 From 1999 to 2010, opioid sales in the United States quadrupled, and in 2012, an estimated 259 million prescriptions for opioid medications were written.…”

Physical and Sexual Dating Violence and Nonmedical Use of Prescription Drugs

“…1 Since 1999, the rate of overdose deaths attributable to prescription opioids and the number of opioid prescriptions have quadrupled. 1,2 Understanding the impact of this epidemic on adolescents is necessary to guide prevention efforts for this population. In the 2015 National Survey on Drug Use and Health, a household survey, it is estimated that nearly 6% of 12-to 17-year-olds misused prescription psychotherapeutic drugs in the past year, whereas in the school-based Monitoring the Future survey, it is reported that a higher annual prevalence of 12.0% among 12th-graders misused prescription psychotherapeutic drugs during the same time period.…”